Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
40,78 USD | +5,04% | +2,25% | -11,03% |
Attività
Numero di dipendenti: 226
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutics
100,0
%
| 24 | 100,0 % | 77 | 100,0 % | +227,56% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
80,6
%
| 24 | 100,0 % | 62 | 80,6 % | +164,09% |
Other
11,5
%
| - | - | 9 | 11,5 % | - |
Germany
7,8
%
| - | - | 6 | 7,8 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Meeker
CEO | Chief Executive Officer | 69 | 01/11/15 |
Hunter Smith
DFI | Director of Finance/CFO | 56 | 01/07/17 |
Joseph Shulman
CTO | Chief Tech/Sci/R&D Officer | 49 | 27/07/20 |
Dana Washburn
CTO | Chief Tech/Sci/R&D Officer | 61 | 26/09/22 |
David Connolly
IRC | Investor Relations Contact | - | 01/05/19 |
Comptroller/Controller/Auditor | 53 | 01/03/23 | |
Corporate Officer/Principal | - | 01/04/21 | |
Pamela Cramer
HRO | Human Resources Officer | 50 | 26/07/21 |
Jim Flaherty
LAW | General Counsel | - | 01/07/19 |
Yann Mazabraud
PRN | Corporate Officer/Principal | 51 | 05/10/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Christophe Jean
BRD | Director/Board Member | 67 | 01/04/15 |
Jennifer Good
BRD | Director/Board Member | 59 | 19/06/19 |
David McGirr
BRD | Director/Board Member | 69 | 01/11/15 |
Director/Board Member | 71 | 09/12/20 | |
Director/Board Member | 64 | 21/03/13 | |
David Meeker
CEO | Chief Executive Officer | 69 | 01/11/15 |
Lynn Tetrault
BRD | Director/Board Member | 61 | 09/12/20 |
Stuart Arbuckle
BRD | Director/Board Member | 58 | 24/07/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 60 972 909 | 57 367 172 ( 94,09 %) | 0 | 94,09 % |
Coordinate società
Rhythm Pharmaceuticals, Inc.
222 Berkeley Street 12th floor
02116-3748, Boston
+857 264 4280
http://www.rhythmtx.comSettore
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-11,03% | 2,37 Mrd | |
-3,08% | 102 Mrd | |
+1,56% | 96,29 Mrd | |
+2,13% | 22,18 Mrd | |
-15,61% | 21,2 Mrd | |
-9,21% | 18,31 Mrd | |
-39,98% | 17,38 Mrd | |
-14,67% | 16,36 Mrd | |
+5,51% | 13,97 Mrd | |
+33,53% | 12,17 Mrd |
- Borsa valori
- Azioni
- Azione RYTM
- Società Rhythm Pharmaceuticals, Inc.